Skip to main content

Animations

MJFF Publications

1821 - 1830 of 6466 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2021
  • 2021
  • 2024
  • 2024
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.773999
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Transition and Sustainability of an Online Care Model for People With Parkinson's Disease in Response to the COVID-19 Pandemic
    Journal Name: Frontiers in Public Health
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fpubh.2021.772805
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Pathological α-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of α-syn in vivo
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.2108489118
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Integrated Genomic, Transcriptomic and Proteomic Analysis for Identifying Markers of Alzheimer’s Disease
    Journal Name: Diagnostics
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/diagnostics11122303
    Citation Count: 16
  • Summary Details
    OPEN
    Title: RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00121-2
    Citation Count: 110
  • Summary Details
    OPEN
    Title: MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00083-8
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Investigation of USP30 inhibition to enhance Parkin-mediated mitophagy: tools and approaches
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20210508
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice
    Journal Name: Cell Reports Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.xcrm.2021.100455
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Parkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegeneration
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awab356
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Trajectory Analysis of Orthostatic Hypotension in Parkinson’s Disease: Results From Parkinson’s Progression Markers Initiative Cohort
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2021.762759
    Citation Count: 10
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.